AI Advancements
AI continues dominating with new efficiencies and applications. Google’s Gemini expands task automation for devices like upcoming Samsung Galaxy S26, handling proactive actions such as booking travel. MIT’s generative AI model accelerates protein-based drug design, potentially slashing pharma R&D costs for diseases like cancer. OpenAI’s GPT-5 improves reasoning while cutting token use by 50-80%, alongside models like Gemini 3.1 Pro doubling benchmarks.
Hardware and Investments
Global IT spending is forecast to hit $6.15 trillion in 2026, up 10.8%, driven by AI infrastructure despite bubble concerns. Meta revises data center deals for higher savings, while AMD’s Ryzen AI 400 boosts laptops. Banks explore quantum tech for fraud detection, and edge computing grows for real-time decisions.